Xvivo Perfusion Valuation
| XVIPF Stock | USD 26.75 1.98 7.99% |
At this time, the company appears to be overvalued. Xvivo Perfusion AB maintains a prevalent Real Value of $25.41 per share. The last-minute price of the company is $26.75. Our model calculates the value of Xvivo Perfusion AB from examining the company fundamentals such as Profit Margin of 0.04 %, shares outstanding of 29.83 M, and Return On Asset of 0.0057 as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Xvivo Perfusion's price fluctuation is not too volatile at this time. Calculation of the real value of Xvivo Perfusion AB is based on 3 months time horizon. Increasing Xvivo Perfusion's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Xvivo pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Xvivo Perfusion AB. Since Xvivo Perfusion is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Xvivo Pink Sheet. However, Xvivo Perfusion's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 26.75 | Real 25.41 | Hype 26.75 | Naive 27.47 |
The real value of Xvivo Pink Sheet, also known as its intrinsic value, is the underlying worth of Xvivo Perfusion AB Company, which is reflected in its stock price. It is based on Xvivo Perfusion's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Xvivo Perfusion's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Xvivo Perfusion AB helps investors to forecast how Xvivo pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Xvivo Perfusion more accurately as focusing exclusively on Xvivo Perfusion's fundamentals will not take into account other important factors: About Xvivo Perfusion Valuation
The pink sheet valuation mechanism determines Xvivo Perfusion's current worth on a weekly basis. Our valuation model uses a comparative analysis of Xvivo Perfusion. We calculate exposure to Xvivo Perfusion's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Xvivo Perfusion's related companies.Xvivo Perfusion AB , a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden. Xvivo Perfusion operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 115 people.
8 Steps to conduct Xvivo Perfusion's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Xvivo Perfusion's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Xvivo Perfusion's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Xvivo Perfusion's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Xvivo Perfusion's revenue streams: Identify Xvivo Perfusion's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Xvivo Perfusion's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Xvivo Perfusion's growth potential: Evaluate Xvivo Perfusion's management, business model, and growth potential.
- Determine Xvivo Perfusion's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Xvivo Perfusion's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Xvivo Perfusion Growth Indicators
Investing in growth stocks can be very risky. If the company such as Xvivo Perfusion does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 29.5 M | |
| Quarterly Earnings Growth Y O Y | -0.951 | |
| Forward Price Earnings | 93.4579 | |
| Retained Earnings | 9.3 M |
Complementary Tools for Xvivo Pink Sheet analysis
When running Xvivo Perfusion's price analysis, check to measure Xvivo Perfusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xvivo Perfusion is operating at the current time. Most of Xvivo Perfusion's value examination focuses on studying past and present price action to predict the probability of Xvivo Perfusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xvivo Perfusion's price. Additionally, you may evaluate how the addition of Xvivo Perfusion to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |